BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Atas E, Oberhuber M, Kenner L. The Implications of PDK1-4 on Tumor Energy Metabolism, Aggressiveness and Therapy Resistance. Front Oncol 2020;10:583217. [PMID: 33384955 DOI: 10.3389/fonc.2020.583217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Scaravilli M, Koivukoski S, Gillen A, Bouazza A, Ruusuvuori P, Visakorpi T, Latonen L. miR-32 promotes MYC-driven prostate cancer. Oncogenesis 2022;11:11. [PMID: 35228520 DOI: 10.1038/s41389-022-00385-8] [Reference Citation Analysis]
2 Zheng X, Xu H, Yi X, Zhang T, Wei Q, Li H, Ai J. Tumor-antigens and immune landscapes identification for prostate adenocarcinoma mRNA vaccine. Mol Cancer 2021;20:160. [PMID: 34872584 DOI: 10.1186/s12943-021-01452-1] [Reference Citation Analysis]
3 Loh D, Reiter RJ. Melatonin: Regulation of Biomolecular Condensates in Neurodegenerative Disorders. Antioxidants (Basel) 2021;10:1483. [PMID: 34573116 DOI: 10.3390/antiox10091483] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Li S, Mai Z, Gu W, Ogbuehi AC, Acharya A, Pelekos G, Ning W, Liu X, Deng Y, Li H, Lethaus B, Savkovic V, Zimmerer R, Ziebolz D, Schmalz G, Wang H, Xiao H, Zhao J. Molecular Subtypes of Oral Squamous Cell Carcinoma Based on Immunosuppression Genes Using a Deep Learning Approach. Front Cell Dev Biol 2021;9:687245. [PMID: 34422810 DOI: 10.3389/fcell.2021.687245] [Reference Citation Analysis]
5 Chen CL, Lin CY, Kung HJ. Targeting Mitochondrial OXPHOS and Their Regulatory Signals in Prostate Cancers. Int J Mol Sci 2021;22:13435. [PMID: 34948229 DOI: 10.3390/ijms222413435] [Reference Citation Analysis]
6 Zhang Z, Han S, Ouyang S, Zeng Z, Liu Z, Sun J, Kang W. PDK4 Constitutes a Novel Prognostic Biomarker and Therapeutic Target in Gastric Cancer. Diagnostics 2022;12:1101. [DOI: 10.3390/diagnostics12051101] [Reference Citation Analysis]
7 Khodaei T, Inamdar S, Suresh A, Acharya AP. Drug delivery for metabolism targeted cancer immunotherapy. Advanced Drug Delivery Reviews 2022. [DOI: 10.1016/j.addr.2022.114242] [Reference Citation Analysis]
8 Kamal S, Derbala HA, Alterary SS, Ben Bacha A, Alonazi M, El-Ashrey MK, Eid El-Sayed NN. Synthesis, Biological, and Molecular Docking Studies on 4,5,6,7-Tetrahydrobenzo[b]thiophene Derivatives and Their Nanoparticles Targeting Colorectal Cancer. ACS Omega 2021;6:28992-9008. [PMID: 34746589 DOI: 10.1021/acsomega.1c04063] [Reference Citation Analysis]
9 Zhou Y, Guo Y, Tam KY. Targeting glucose metabolism to develop anticancer treatments and therapeutic patents. Expert Opin Ther Pat 2022. [PMID: 35001793 DOI: 10.1080/13543776.2022.2027912] [Reference Citation Analysis]
10 Chen W, Zhang T, Bai Y, Deng H, Yang F, Zhu R, Chen Y, He Z, Zeng Q, Song M. Upregulated circRAD18 promotes tumor progression by reprogramming glucose metabolism in papillary thyroid cancer. Gland Surg 2021;10:2500-10. [PMID: 34527562 DOI: 10.21037/gs-21-481] [Reference Citation Analysis]
11 Wiebringhaus R, Pecoraro M, Neubauer HA, Trachtová K, Trimmel B, Wieselberg M, Pencik J, Egger G, Krall C, Moriggl R, Mann M, Hantusch B, Kenner L. Proteomic Analysis Identifies NDUFS1 and ATP5O as Novel Markers for Survival Outcome in Prostate Cancer. Cancers (Basel) 2021;13:6036. [PMID: 34885151 DOI: 10.3390/cancers13236036] [Reference Citation Analysis]
12 Zhang Y, Zhu B, Cai Y, Zhu S, Zhao H, Ying X, Jiang C, Zeng J. Alteration in glycolytic/cholesterogenic gene expression is associated with bladder cancer prognosis and immune cell infiltration. BMC Cancer 2022;22:2. [PMID: 34980012 DOI: 10.1186/s12885-021-09064-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]